Projects

LIV officially became an independent research unit in 2022. So far, the LIV staff has undertaken more than 40 scientific research projects, funded with over 20 million yuan, including the National Natural Science Foundation of China, the Ministry of Science and Technology, the Department of Science and Technology of Guangdong Province, and Shenzhen Representative projects include:

Immunology Research Network of Vaccine Innovation

Type of Project: Bill and Melinda Gates Foundation

Director: Diana Boraschi

Process time: 2023-2025

Detection of cell-mediated antiviral immunity and evaluation of host antiviral immunity

Type of Project: CAS-ANSO Joint Research

Director: Diana Boraschi

Process time: 2022-2024

Design of Nanomaterials Specifically Occupying Infection Sites of S Protein and Study on Their Resistance to COVID-19

Project type: MOST

Director: Yang Li

Process time: 2021-2024

A novel synthesis of curcumin loaded H2@C40-liquid crystal for hydrogen oncotherapy

Type of project：NSFC
Director：Nahar Jannatun
Process time：2023-2024

Immunotoxicological effect and mechanism of metal organic framework nanomaterial ZIF-8

Type of project: NSFC
Director: Guofang Zhang
Process time: 2023-2025

Assessment of human immune response for SARS-CoV-2 and development of diagnostic tools for host susceptibility

Type of project: NSFC
Director: Yang Li
Process time: 2022-2025

Analysis of long-term and short-term toxicity and immuno safety of micro-plastic particles after gastrointestinal tract exposure